United States · FDA National Drug Code directory

Paclitaxel

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 75007-041_c455b438-d057-4568-a66a-68775a878fdc
Product NDC: 75007-041
Form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Composition / generic term: Paclitaxel (aibumin-bound)
Labeler: Ningbo Shuangcheng Pharmaceutical Co., Ltd
Marketing category: ANDA
Marketing start / end (source format): 20250515
Source listing expiry: 20271231

Source-listed ingredients

PACLITAXEL — 100 mg/100mg

These values do not establish equivalence or a dose recommendation.

Packages

Package details are not available in this snapshot.

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →